Most Recent
CIMIC to face non-use cross-claim in suit over Leyton trade mark
CIMIC faces a cross-claim in its trade mark infringement case against developer Leyton Property, which wants the building giant's Leighton marks removed from the registry for non-use.
Coles advertised ‘utterly misleading’ discounts to compete with Woolworths, says ACCC
Coles changed its marketing policies after being concerned it could not compete with Woolworths, a court has heard on the first day of trial in the consumer regulator’s case over the supermarket's “utterly misleading” discounts.
Construction PRO
Allied Pinnacle scores partial win in fight over commercial lease
Allied Pinnacle has partially succeeded in its fight over a commercial lease in Western Sydney, with a judge finding the baked goods supplier did not have to remove its fit out at the conclusion of its lease, but did have to repaint the external walls.
Construction PRO
CIMIC faces cross-claim in trade mark row with Leyton Property
In response to a trade mark infringement case by CIMIC, developer Leyton Property is bringing a cross-claim that argues the building giant should lose its Leighton marks for non-use.
CBA to file cross-appeal with High Court in shareholder class actions
CBA plans to file a cross-appeal in the class actions before the High Court, contending the shareholders -- who argue they should have won their loss case -- failed to establish disclosure breaches at the threshold.
Keystone’s Paul Chiodo can’t dodge receivers’ subpoenas for bank records
Ex-Keystone director Paul Chiodo has failed in his fight against subpoenas by receivers over bank statements, despite arguing they were a fishing expedition aimed at clawing back investor funds. 
Class action against ADF says sex discrimination law applies overseas
A landmark class action over alleged systematic sexual violence, discrimination and harassment in the Australian Defence Force will argue that the Sex Discrimination Act applies to incidents that occurred overseas.
AstraZeneca wins injunction against Pharmacor’s generic diabetes drug
AstraZeneca has won an interlocutory injunction barring Pharmacor from making a generic version of its blockbuster diabetes drug Forxiga while a patent case over the drug proceeds.
Twitter defeats case over replies to alleged defamatory tweets
A judge has ruled that a self-represented litigant who settled proceedings against Twitter in 2021 over alleged defamatory tweets cannot pursue a case over replies later made to those tweets.
Ashurst nabs insolvency lawyer from HWL Ebsworth
Ashurst has appointed a new partner to its restructuring and governance practice, nabbing a partner from HWL Ebsworth who represented the receivers of investment platform Brite Advisors.